Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PENN Entertainment
PENN
$2.71B
| $44.3M | ﹤0.01% |
2,347,551
-150,352
| -6% | -$2.86M |
|
1502
Novavax
NVAX
$1.31B
| $44.2M | ﹤0.01% |
3,502,489
+304,159
| +10% | +$3.93M |
|
1503
Acadia Pharmaceuticals
ACAD
$5.03B
| $44.2M | ﹤0.01% |
2,875,540
+30,826
| +1% | +$514K |
|
1504
Privia Health
PRVA
$2.87B
| $44M | ﹤0.01% |
2,415,022
+23,178
| +1% | +$442K |
|
1505
IPG Photonics
IPGP
$3.84B
| $43.9M | ﹤0.01% |
590,634
-5,018
| -0.8% | -$375K |
|
1506
STAAR Surgical
STAA
$1.21B
| $43.6M | ﹤0.01% |
1,174,499
+31,212
| +3% | +$1.16M |
|
1507
Huron Consulting
HURN
$2.42B
| $43.6M | ﹤0.01% |
400,586
-14,095
| -3% | -$1.5M |
|
1508
Plug Power
PLUG
$3.04B
| $43.4M | ﹤0.01% |
19,194,629
+3,662,456
| +24% | +$8.21M |
|
1509
Photronics
PLAB
$1.93B
| $43.2M | ﹤0.01% |
1,745,165
+85,160
| +5% | +$2.06M |
|
1510
Immunovant
IMVT
$8.25B
| $43.1M | ﹤0.01% |
1,510,926
+96,924
| +7% | +$2.86M |
|
1511
Azenta
AZTA
$1.48B
| $43.1M | ﹤0.01% |
888,737
-59,330
| -6% | -$3.09M |
|
|
B
1512
DELISTED
Barnes Group Inc.
B
| $43.1M | ﹤0.01% |
1,065,164
-36,633
| -3% | -$1.44M |
|
1513
Boston Beer
SAM
$1.92B
| $42.9M | ﹤0.01% |
148,389
-3,810
| -3% | -$1.06M |
|
1514
Global Net Lease
GNL
$1.95B
| $42.9M | ﹤0.01% |
5,093,659
+95,769
| +2% | +$804K |
|
1515
Ligand Pharmaceuticals
LGND
$6.36B
| $42.9M | ﹤0.01% |
428,270
+22,495
| +6% | +$2.26M |
|
1516
Stantec
STN
$8.39B
| $42.8M | ﹤0.01% |
523,581
+46,267
| +10% | +$3.83M |
|
|
RCM
1517
DELISTED
R1 RCM Inc. Common Stock
RCM
| $42.7M | ﹤0.01% |
3,012,806
-413,124
| -12% | -$5.61M |
|
1518
Edgewise Therapeutics
EWTX
$4.73B
| $42.7M | ﹤0.01% |
1,599,535
-73,118
| -4% | -$1.45M |
|
1519
PAR Technology
PAR
$735M
| $42.7M | ﹤0.01% |
819,035
+81,551
| +11% | +$4.24M |
|
1520
Kosmos Energy
KOS
$1.48B
| $42.6M | ﹤0.01% |
10,580,979
+68,339
| +0.7% | +$333K |
|
1521
Virtu Financial
VIRT
$4.93B
| $42.6M | ﹤0.01% |
1,397,056
-79,091
| -5% | -$2.25M |
|
1522
John Wiley & Sons Class A
WLY
$2.66B
| $42.6M | ﹤0.01% |
881,708
-296
| -0% | -$13.6K |
|
1523
Howard Hughes
HHH
$4.03B
| $42.5M | ﹤0.01% |
548,817
-41,761
| -7% | -$2.95M |
|
1524
ADT
ADT
$5.58B
| $42.5M | ﹤0.01% |
5,875,140
+1,543,677
| +36% | +$11.3M |
|
1525
BOK Financial
BOKF
$8.74B
| $42.4M | ﹤0.01% |
405,542
-46,535
| -10% | -$4.68M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.